Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2018 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: Robohogs who wrote (168)	8/13/2018 2:03:40 AM
From: Robohogs	Respond to of 220

That missed the impact of some dying (stockwise) larger companies too. $AXGN $BPMC etc. what goes up too fast......

To: Robohogs who wrote (168)	8/13/2018 3:34:28 PM
From: BulbaMan	Respond to of 220

Thanks for the insight, Robo. What you note is reflected in my 6/15/18 Contest update as compared to my 8/10/18 update this past Friday. On 6/15/18 I wrote: “The 230 Contest stock picks have an average YTD gain of 14.01% and a median YTD gain of 1.66%, with 118 showing a gain for the year.” On 8/10/18 I wrote: “The 230 Contest stock picks have an average YTD gain of 5.63% and a median YTD loss of -7.40%, with 97 showing a gain for the year.” However, despite the large downturn for the Contest portfolios in general, the YTD gain by Contest leader KMASTR’s portfolio, holding ARQL and XENE, was about the same on 8/10/18 as on 6/15/18: 78.02% YTD vs. 78.81% YTD. Peace & good health, Bulba